{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:17:12Z","timestamp":1780438632523,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.prro.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T05:47:19Z","timestamp":1742622439000},"page":"e424-e433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Six-Year Results From a Prospective Phase 2 Trial of 10-Fraction Hypofractionated Radiation Therapy in Locally Advanced Breast Cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"Paola","family":"Pinnar\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-4188","authenticated-orcid":false,"given":"Silvia","family":"Takanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Soriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Vici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sperati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.03.002_bib0001","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.03.002_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.radonc.2020.10.008","article-title":"Hypofractionated radiation therapy for breast cancer: preferences amongst radiation oncologists in Europe - results from an international survey","volume":"155","author":"Ratosa","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0003","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2025.03.002_bib0004","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0005","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0006","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.03.002_bib0007","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0008","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","article-title":"Moderately hypofractionated post-operative radiation therapy for breast cancer: systematic review and meta-analysis of randomized clinical trials","volume":"62","author":"Marta","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.prro.2025.03.002_bib0009","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000521552","article-title":"Expert discussion: hypofractionated radiation therapy - standard for all indications?","volume":"17","author":"Fastner","year":"2022","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.prro.2025.03.002_bib0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0360-3016(90)90216-7","article-title":"The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients","volume":"19","author":"Baillet","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0011","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.2016.70.7158","article-title":"Hypofractionated postmastectomy radiation therapy is safe and effective: first results from a prospective phase II trial","volume":"35","author":"Khan","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0012","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0013","unstructured":"NCCN Guidelines Version 1. 2024 Invasive Breast Cancer. www.nccn.org\/guidelines\/guidelines. Accessed September 10, 2024."},{"key":"10.1016\/j.prro.2025.03.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103090","article-title":"The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review","volume":"156","author":"Marta","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.prro.2025.03.002_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-9966-29-9","article-title":"Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years","volume":"29","author":"Pinnar\u00f2","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.prro.2025.03.002_bib0016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-017-0640-z","article-title":"Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study","volume":"36","author":"Pinnar\u00f2","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.prro.2025.03.002_bib0017","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijrobp.2012.08.017","article-title":"Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection","volume":"85","author":"Koukourakis","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0018","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.03.002_bib0019","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.03.002_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0021","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.ijrobp.2021.07.778","article-title":"Ten fraction adjuvant hypofractionated radiotherapy in node positive breast cancer: 3 year-follow-up of a phase II toxicity study","volume":"111","author":"Pinnaro","year":"2021","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0022","first-page":"s136","article-title":"5-year results from a prospective phase II trial of ten-fractions hypofractionated radiotherapy in locally advanced breast cancer","volume":"117","author":"Pinnaro","year":"2023","journal-title":"Rad Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0023","unstructured":"Breast Cancer Atlas. https:\/\/www.rtog.org\/CoreLab\/ContouringAtlases\/BreastCancerAtlas.aspx. Accessed August 27, 2024."},{"key":"10.1016\/j.prro.2025.03.002_bib0024","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/0284186X.2013.765064","article-title":"Danish Breast Cancer Cooperative Group Radiotherapy Committee. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group","volume":"52","author":"Nielsen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0025","unstructured":"International Commission on Radiation Units and Measurements: Prescribing, recording and reporting photon beam therapy: ICRU report 50 Bethesda: International Commission on Radiation Units and Measurements. 1993. www.icru.org\/report\/prescribing-recording-and-reporting-photon-beam-therapy-report-50. Accessed November 28, 2024."},{"key":"10.1016\/j.prro.2025.03.002_bib0026","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2009"},{"key":"10.1016\/j.prro.2025.03.002_bib0027","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0360-3016(95)90159-0","article-title":"LENT SOMA scales for all anatomic sites","volume":"31","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0028","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.3747\/co.25.4036","article-title":"Patient-reported outcome measurement compared with professional judgment of cosmetic results after breast-conserving therapy","volume":"25","author":"Brands-Appeldoorn","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0029","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0360-3016(00)00782-3","article-title":"Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation. Radiation Therapy Oncology Group (RTOG)","volume":"48","author":"Fisher","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0360-3016(02)04120-2","article-title":"Long term radiation sequelae after breast conserving therapy in women with early breast cancer: an observational study using the LENT-SOMA scoring system","volume":"55","author":"Fehlauer","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0031","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijrobp.2023.07.011","article-title":"American Radium Society appropriate use criteria postmastectomy radiation therapy: executive summary of clinical topics","volume":"118","author":"Novick","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.prro.2025.03.002_bib0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-7-80","article-title":"Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial","volume":"1","author":"Van Parijs","year":"2012","journal-title":"Radiat Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.prro.2025.03.002_bib0033","first-page":"S94","article-title":"A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer","volume":"94","author":"Pinitpatcharalert","year":"2011","journal-title":"J Med Assoc Thai"},{"issue":"21","key":"10.1016\/j.prro.2025.03.002_bib0034","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1186\/s12885-021-09032-8","article-title":"Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions","volume":"1","author":"Jiang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2025.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ejso.2015.07.011","article-title":"The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy","volume":"41","author":"Lansu","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0036","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijrobp.2023.06.215","article-title":"Largest real-world data of regional nodal irradiation using ultra-hypofractionated 5-fraction adjuvant radiation therapy for breast cancer from a Single Institute in India","volume":"117","author":"Pathak","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0037","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s13063-020-04751-y","volume":"30","author":"Chatterjee","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.prro.2025.03.002_bib0038","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.002_bib0039","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.ijrobp.2023.08.029","article-title":"Patient-reported and toxicity results from the FABREC Study: a multicenter randomized trial of hypofractionated vs. conventionally-fractionated postmastectomy radiation therapy after implant-based reconstruction","volume":"117","author":"Wong","year":"2023","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.002_bib0040","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ijrobp.2024.07.002","article-title":"A randomized trial of hypofractionated postmastectomy radiation therapy (PMRT) in women with breast reconstruction (RT CHARM, Alliance A221505)","volume":"120","author":"Poppe","year":"2024","journal-title":"Int J Rad Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:41:02Z","timestamp":1756456862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850025000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1879850025000669"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.03.002","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Six-Year Results From a Prospective Phase 2 Trial of 10-Fraction Hypofractionated Radiation Therapy in Locally Advanced Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}